Screener
Pacira BioSciences, Inc. PCRX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
FAQ
- What is Pacira BioSciences, Inc.'s return on equity?
- Pacira BioSciences, Inc. (PCRX) reported return on equity of 0.7% in Q1 2026.
- What is the long-term trend for Pacira BioSciences, Inc.'s return on equity?
- Over 2 years (2020 to 2025), Pacira BioSciences, Inc.'s return on equity has grown at a -82.1% compound annual growth rate (CAGR), from 29.9% to 1%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Pacira BioSciences, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude